
The general assumption that the Policy 0070 data releases were public data releases can be challenged since there is a mechanism to enforce the ToU, and this mechanism will continue to exist after the Agency moves to the Netherlands.
The general assumption that the Policy 0070 data releases were public data releases can be challenged since there is a mechanism to enforce the ToU, and this mechanism will continue to exist after the Agency moves to the Netherlands.
How much does the EU really care about health, and about the infrastructure that is a precondition to successful healthcare and healthcare innovation?
The right-to-try gale is now blowing at full strength in the US and is likely to prove a straw in the wind that could become a haystack.
In this article, we will demonstrate a methodology that resulted in improving CRA performance.
Updated employee announcements, business news, awards, and recognition in the industry today.
Certified principal investigator certification as a predictor of major and critical protocol deviations in clinical trials.
Liquid biopsy, typically non-invasive blood-based tests for circulating tumor DNA and circulating tumor cells, has been long-hyped as a potential game-changer for cancer treatment.